Relationship among α‑synuclein, aging and inflammation in Parkinson's disease (Review)
- Authors:
- Nianping Zhang
- Zhaoli Yan
- Hua Xin
- Shuai Shao
- Song Xue
- Raymond Cespuglio
- Shijun Wang
-
Affiliations: Postdoctoral Mobile Station, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250355, P.R. China, Department of Neurosurgery, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250014, P.R. China, Department of Neurology, People's Hospital of Rizhao, Rizhao, Shandong 276800, P.R. China, Department of Reproductive Medicine, Jingmen People's Hospital, Jingmen, Hubei 448000, P.R. China, Experimental Center, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250355, P.R. China, Neuroscience Research Center of Lyon (CNRL), Claude‑Bernard Lyon‑1 University, 69500 Lyon, France, Department of Pathology, College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250355, P.R. China - Published online on: November 21, 2023 https://doi.org/10.3892/etm.2023.12311
- Article Number: 23
-
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
 |
 |
|
Zhu B, Yin D, Zhao H and Zhang L: The immunology of Parkinson's disease. Semin Immunopathol. 44:659–672. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Jang JH, Yeom MJ, Ahn S, Oh JY, Ji S, Kim TH and Park HJ: Acupuncture inhibits neuroinflammation and gut microbial dysbiosis in a mouse model of Parkinson's disease. Brain Behav Immun. 89:641–655. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Fields CR, Bengoa-Vergniory N and Wade-Martins R: Targeting alpha-synuclein as a therapy for Parkinson's disease. Front Mol Neurosci. 12(299)2019.PubMed/NCBI View Article : Google Scholar | |
|
Zhao Y, Zhang Z, Qin S, Fan W, Li W, Liu J, Wang S, Xu Z and Zhao M: Acupuncture for Parkinson's disease: Efficacy evaluation and mechanisms in the dopaminergic neural circuit. Neural Plast. 2021(9926445)2021.PubMed/NCBI View Article : Google Scholar | |
|
Stevenson TJ, Murray HC, Turner C, Faull RLM, Dieriks BV and Curtis MA: α-synuclein inclusions are abundant in non-neuronal cells in the anterior olfactory nucleus of the Parkinson's disease olfactory bulb. Sci Rep. 10(6682)2020.PubMed/NCBI View Article : Google Scholar | |
|
Campo F, Carletti R, Fusconi M, Pellicano C, Pontieri FE, Di Gioia CR and de Vincentiis M: Alpha-synuclein in salivary gland as biomarker for Parkinson's disease. Rev Neurosci. 30:455–462. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Jansen van Rensburg Z, Abrahams S, Bardien S and Kenyon C: Toxic feedback loop involving iron, reactive oxygen species, α-synuclein and neuromelanin in Parkinson's disease and intervention with turmeric. Mol Neurobiol. 58:5920–5936. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Guerrero-Ferreira R, Taylor NM, Mona D, Ringler P, Lauer ME, Riek R, Britschgi M and Stahlberg H: Cryo-EM structure of alpha-synuclein fibrils. Elife. 7(e36402)2018.PubMed/NCBI View Article : Google Scholar | |
|
Vasquez V, Mitra J, Wang H, Hegde PM, Rao KS and Hegde ML: A multi-faceted genotoxic network of alpha-synuclein in the nucleus and mitochondria of dopaminergic neurons in Parkinson's disease: Emerging concepts and challenges. Prog Neurobiol. 185(101729)2020.PubMed/NCBI View Article : Google Scholar | |
|
Burré J, Sharma M and Südhof TC: Cell biology and pathophysiology of α-synuclein. Cold Spring Harb Perspect Med. 8(a024091)2018.PubMed/NCBI View Article : Google Scholar | |
|
Fujioka S, Ogaki K, Tacik PM, Uitti RJ, Ross OA and Wszolek ZK: Update on novel familial forms of Parkinson's disease and multiple system atrophy. Parkinsonism Relat Disord. 20 (Suppl 1):S29–S34. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Koo HJ, Lee HJ and Im H: Sequence determinants regulating fibrillation of human alpha-synuclein. Biochem Biophys Res Commun. 368:772–778. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Liu W, Lim KL and Tan EK: Intestine-derived α-synuclein initiates and aggravates pathogenesis of Parkinson's disease in Drosophila. Transl Neurodegener. 11(44)2022.PubMed/NCBI View Article : Google Scholar | |
|
Choi ML, Chappard A, Singh BP, Maclachlan C, Rodrigues M, Fedotova EI, Berezhnov AV, De S, Peddie CJ, Athauda D, et al: Pathological structural conversion of α-synuclein at the mitochondria induces neuronal toxicity. Nat Neurosci. 25:1134–1148. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Pacheco CR, Morales CN, Ramírez AE, Muñoz FJ, Gallegos SS, Caviedes PA, Aguayo LG and Opazo CM: Extracellular α-synuclein alters synaptic transmission in brain neurons by perforating the neuronal plasma membrane. J Neurochem. 132:731–741. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Cardinale A, Calabrese V, de Iure A and Picconi B: Alpha-synuclein as a prominent actor in the inflammatory synaptopathy of Parkinson's disease. Int J Mol Sci. 22(6517)2021.PubMed/NCBI View Article : Google Scholar | |
|
Chakroun T, Evsyukov V, Nykänen NP, Höllerhage M, Schmidt A, Kamp F, Ruf VC, Wurst W, Rösler TW and Höglinger GU: Alpha-synuclein fragments trigger distinct aggregation pathways. Cell Death Dis. 11(84)2020.PubMed/NCBI View Article : Google Scholar | |
|
Wang C, Yang T, Liang M, Xie J and Song N: Astrocyte dysfunction in Parkinson's disease: From the perspectives of transmitted α-synuclein and genetic modulation. Transl Neurodegener. 10(39)2021.PubMed/NCBI View Article : Google Scholar | |
|
Yu WW, Cao SN, Zang CX, Wang L, Yang HY, Bao XQ and Zhang D: Heat shock protein 70 suppresses neuroinflammation induced by α-synuclein in astrocytes. Mol Cell Neurosci. 86:58–64. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Kim C, Spencer B, Rockenstein E, Yamakado H, Mante M, Adame A, Fields JA, Masliah D, Iba M, Lee HJ, et al: Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation. Mol Neurodegener. 13(43)2018.PubMed/NCBI View Article : Google Scholar | |
|
Sian-Hulsmann J and Riederer P: The role of alpha-synuclein as ferrireductase in neurodegeneration associated with Parkinson's disease. J Neural Transm (Vienna). 127:749–754. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Riederer P, Monoranu C, Strobel S, Iordache T and Sian-Hülsmann J: Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson's disease. J Neural Transm (Vienna). 128:1577–1598. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Melo TQ, Copray SJCVM and Ferrari MFR: Alpha-synuclein toxicity on protein quality control, mitochondria and endoplasmic reticulum. Neurochem Res. 43:2212–2223. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Ninkina N, Tarasova TV, Chaprov KD, Roman AY, Kukharsky MS, Kolik LG, Ovchinnikov R, Ustyugov AA, Durnev AD and Buchman VL: Alterations in the nigrostriatal system following conditional inactivation of α-synuclein in neurons of adult and aging mice. Neurobiol Aging. 91:76–87. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE and Joers V: Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol. 22:657–673. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Zhao YF, Qiong-Zhang Zhang JF, Lou ZY, Zu HB, Wang ZG, Zeng WC and Kai-Yao and Xiao BG: The synergy of aging and LPS exposure in a mouse model of Parkinson's disease. Aging Dis. 9:785–797. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Russo T and Riessland M: Age-related midbrain inflammation and senescence in Parkinson's disease. Front Aging Neurosci. 14(917797)2022.PubMed/NCBI View Article : Google Scholar | |
|
Su R and Zhou T: Alpha-synuclein induced immune cells activation and associated therapy in Parkinson's disease. Front Aging Neurosci. 13(769506)2021.PubMed/NCBI View Article : Google Scholar | |
|
Tremblay ME, Cookson MR and Civiero L: Glial phagocytic clearance in Parkinson's disease. Mol Neurodegener. 14(16)2019.PubMed/NCBI View Article : Google Scholar | |
|
Kim C, Kwon S, Iba M, Spencer B, Rockenstein E, Mante M, Adame A, Shin SJ, Fields JA, Rissman RA, et al: Effects of innate immune receptor stimulation on extracellular α-synuclein uptake and degradation by brain resident cells. Exp Mol Med. 53:281–290. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Fellner L, Gabassi E, Haybaeck J and Edenhofer F: Autophagy in α-synucleinopathies-an overstrained system. Cells. 10(3143)2021.PubMed/NCBI View Article : Google Scholar | |
|
Caggiu E, Arru G, Hosseini S, Niegowska M, Sechi G, Zarbo IR and Sechi LA: Inflammation, infectious triggers, and Parkinson's disease. Front Neurol. 10(122)2019.PubMed/NCBI View Article : Google Scholar | |
|
Salminen A, Ojala J, Kaarniranta K, Haapasalo A, Hiltunen M and Soininen H: Astrocytes in the aging brain express characteristics of senescence-associated secretory phenotype. Eur J Neurosci. 34:3–11. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Coleman C and Martin I: Unraveling Parkinson's disease neurodegeneration: Does aging hold the clues? J Parkinsons Dis. 12:2321–2338. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Pang SY, Ho PW, Liu HF, Leung CT, Li L, Chang EES, Ramsden DB and Ho SL: The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson's disease. Transl Neurodegener. 8(23)2019.PubMed/NCBI View Article : Google Scholar | |
|
Wendimu MY and Hooks SB: Microglia phenotypes in aging and neurodegenerative diseases. Cells. 11(2091)2022.PubMed/NCBI View Article : Google Scholar | |
|
Nasrolahi A, Safari F, Farhoudi M, Khosravi A, Farajdokht F, Bastaminejad S, Sandoghchian Shotorbani S and Mahmoudi J: Immune system and new avenues in Parkinson's disease research and treatment. Rev Neurosci. 30:709–727. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Van Den Berge N, Ferreira N, Mikkelsen TW, Alstrup AKO, Tamgüney G, Karlsson P, Terkelsen AJ, Nyengaard JR, Jensen PH and Borghammer P: Ageing promotes pathological alpha-synuclein propagation and autonomic dysfunction in wild-type rats. Brain. 144:1853–1868. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Challis C, Hori A, Sampson TR, Yoo BB, Challis RC, Hamilton AM, Mazmanian SK, Volpicelli-Daley LA and Gradinaru V: Gut-seeded α-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice. Nat Neurosci. 23:327–336. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Verma DK, Seo BA, Ghosh A, Ma SX, Hernandez-Quijada K, Andersen JK, Ko HS and Kim YH: Alpha-synuclein preformed fibrils induce cellular senescence in Parkinson's disease models. Cells. 10(1694)2021.PubMed/NCBI View Article : Google Scholar | |
|
Rotter A, Lenz B, Pitsch R, Richter-Schmidinger T, Kornhuber J and Rhein C: Alpha-synuclein RNA expression is increased in major depression. Int J Mol Sci. 20(2029)2019.PubMed/NCBI View Article : Google Scholar | |
|
Phan HTM, Bartz JC, Ayers J, Giasson BI, Schubert M, Rodenhausen KB, Kananizadeh N, Li Y and Bartelt-Hunt SL: Adsorption and decontamination of α-synuclein from medically and environmentally-relevant surfaces. Colloids Surf B Biointerfaces. 166:98–107. 2018.PubMed/NCBI View Article : Google Scholar | |
|
D'Onofrio M, Munari F and Assfalg M: Alpha-synuclein-nanoparticle interactions: Understanding, controlling and exploiting conformational plasticity. Molecules. 25(5625)2020.PubMed/NCBI View Article : Google Scholar | |
|
Makasewicz K, Wennmalm S, Stenqvist B, Fornasier M, Andersson A, Jönsson P, Linse S and Sparr E: Cooperativity of α-synuclein binding to lipid membranes. ACS Chem Neurosci. 12:2099–2109. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Davidson WS, Jonas A, Clayton DF and George JM: Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem. 273:9443–9449. 1998.PubMed/NCBI View Article : Google Scholar | |
|
George JM, Jin H, Woods WS and Clayton DF: Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron. 15:361–372. 1995.PubMed/NCBI View Article : Google Scholar | |
|
Uéda K, Fukushima H, Masliah E, Xia Y, Iwai A, Yoshimoto M, Otero DA, Kondo J, Ihara Y and Saitoh T: Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci USA. 90:11282–11286. 1993.PubMed/NCBI View Article : Google Scholar | |
|
Weinreb PH, Zhen W, Poon AW, Conway KA and Lansbury PT Jr: NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry. 35:13709–13715. 1996.PubMed/NCBI View Article : Google Scholar | |
|
Acquasaliente L, Pontarollo G, Radu CM, Peterle D, Artusi I, Pagotto A, Uliana F, Negro A, Simioni P and De Filippis V: Exogenous human α-synuclein acts in vitro as a mild platelet antiaggregant inhibiting α-thrombin-induced platelet activation. Sci Rep. 12(9880)2022.PubMed/NCBI View Article : Google Scholar | |
|
Dedmon MM, Lindorff-Larsen K, Christodoulou J, Vendruscolo M and Dobson CM: Mapping long-range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simulations. J Am Chem Soc. 127:476–477. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Bogale TA, Faustini G, Longhena F, Mitola S, Pizzi M and Bellucci A: Alpha-synuclein in the regulation of brain endothelial and perivascular cells: Gaps and future perspectives. Front Immunol. 12(611761)2021.PubMed/NCBI View Article : Google Scholar | |
|
Bozelli JC Jr, Kamski-Hennekam E, Melacini G and Epand RM: α-Synuclein and neuronal membranes: Conformational flexibilities in health and disease. Chem Phys Lipids. 235(105034)2021.PubMed/NCBI View Article : Google Scholar | |
|
Chakraborty R and Chattopadhyay K: Cryo-electron microscopy uncovers key residues within the core of alpha-synuclein fibrils. ACS Chem Neurosci. 10:1135–1136. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Walsh DM and Selkoe DJ: A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration. Nat Rev Neurosci. 17:251–260. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Choi ML and Gandhi S: Crucial role of protein oligomerization in the pathogenesis of Alzheimer's and Parkinson's diseases. FEBS J. 285:3631–3644. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Liu G, Aliaga L and Cai H: α-Synuclein, LRRK2 and their interplay in Parkinson's disease. Future Neurol. 7:145–153. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Wang R, Ren H, Kaznacheyeva E, Lu X and Wang G: Association of glial activation and α-synuclein pathology in Parkinson's disease. Neurosci Bull. 39:479–490. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Imbriani P, Schirinzi T, Meringolo M, Mercuri NB and Pisani A: Centrality of early synaptopathy in Parkinson's disease. Front Neurol. 9(103)2018.PubMed/NCBI View Article : Google Scholar | |
|
Kam TI, Mao X, Park H, Chou SC, Karuppagounder SS, Umanah GE, Yun SP, Brahmachari S, Panicker N, Chen R, et al: Poly(ADP-ribose) drives pathologic α-synuclein neurodegeneration in Parkinson's disease. Science. 362(eaat8407)2018.PubMed/NCBI View Article : Google Scholar | |
|
Bae EJ, Choi M, Kim JT, Kim DK, Jung MK, Kim C, Kim TK, Lee JS, Jung BC, Shin SJ, et al: TNF-α promotes α-synuclein propagation through stimulation of senescence-associated lysosomal exocytosis. Exp Mol Med. 54:788–800. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Gelpi E, Navarro-Otano J, Tolosa E, Gaig C, Compta Y, Rey MJ, Martí MJ, Hernández I, Valldeoriola F, Reñé R and Ribalta T: Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders. Mov Disord. 29:1010–1018. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Donadio V, Incensi A, Piccinini C, Cortelli P, Giannoccaro MP, Baruzzi A and Liguori R: Skin nerve misfolded α-synuclein in pure autonomic failure and Parkinson disease. Ann Neurol. 79:306–316. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Beach TG, Adler CH, Sue LI, Vedders L, Lue L, White Iii CL, Akiyama H, Caviness JN, Shill HA, Sabbagh MN, et al: Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol. 119:689–702. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Braak H, Rüb U, Gai WP and Del Tredici K: Idiopathic Parkinson's disease: Possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm (Vienna). 110:517–536. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Braak H, Ghebremedhin E, Rüb U, Bratzke H and Del Tredici K: Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res. 318:121–134. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Liu B, Fang F, Pedersen NL, Tillander A, Ludvigsson JF, Ekbom A, Svenningsson P, Chen H and Wirdefeldt K: Vagotomy and Parkinson disease: A Swedish register-based matched-cohort study. Neurology. 88:1996–2002. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Ho PW, Leung CT, Liu H, Pang SY, Lam CS, Xian J, Li L, Kung MH, Ramsden DB and Ho SL: Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: Role for therapeutic activation of chaperone-mediated autophagy (CMA). Autophagy. 16:347–370. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Henderson MX, Trojanowski JQ and Lee VMY: α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies. Neurosci Lett. 709(134316)2019.PubMed/NCBI View Article : Google Scholar | |
|
Iba M, McDevitt RA, Kim C, Roy R, Sarantopoulou D, Tommer E, Siegars B, Sallin M, Kwon S, Sen JM, et al: Aging exacerbates the brain inflammatory micro-environment contributing to α-synuclein pathology and functional deficits in a mouse model of DLB/PD. Mol Neurodegener. 17(60)2022.PubMed/NCBI View Article : Google Scholar | |
|
Rauschenberger L, Behnke J, Grotemeyer A, Knorr S, Volkmann J and Ip CW: Age-dependent neurodegeneration and neuroinflammation in a genetic A30P/A53T double-mutated α-synuclein mouse model of Parkinson's disease. Neurobiol Dis. 171(105798)2022.PubMed/NCBI View Article : Google Scholar | |
|
Yang W, Li X, Li X and Yu S: Hemoglobin-α-synuclein complex exhibited age-dependent alterations in the human striatum and peripheral RBCs. Neurosci Lett. 736(135274)2020.PubMed/NCBI View Article : Google Scholar | |
|
Ma M, Li H, Wu J, Zhang Y, Shen H, Li X, Wang Z and Chen G: Roles of prokineticin 2 in subarachnoid hemorrhage-induced early brain injury via regulation of phenotype polarization in astrocytes. Mol Neurobiol. 57:3744–3758. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Jeon YM, Kwon Y, Jo M, Lee S, Kim S and Kim HJ: The role of glial mitochondria in alpha-synuclein toxicity. Front Cell Dev Biol. 8(548283)2020.PubMed/NCBI View Article : Google Scholar | |
|
Li Q and Haney MS: The role of glia in protein aggregation. Neurobiol Dis. 143(105015)2020.PubMed/NCBI View Article : Google Scholar | |
|
Wang P and Ye Y: Astrocytes in neurodegenerative diseases: A perspective from tauopathy and α-synucleinopathy. Life (Basel). 11(938)2021.PubMed/NCBI View Article : Google Scholar | |
|
Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, Bennett ML, Münch AE, Chung WS, Peterson TC, et al: Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 541:481–487. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Diniz LP, Araujo APB, Matias I, Garcia MN, Barros-Aragão FGQ, de Melo Reis RA, Foguel D, Braga C, Figueiredo CP, Romão L and Gomes FCA: Astrocyte glutamate transporters are increased in an early sporadic model of synucleinopathy. Neurochem Int. 138(104758)2020.PubMed/NCBI View Article : Google Scholar | |
|
Chavarria C, Ivagnes R and Souza JM: Extracellular alpha-synuclein: Mechanisms for glial cell internalization and activation. Biomolecules. 12(655)2022.PubMed/NCBI View Article : Google Scholar | |
|
Vargas JY, Grudina C and Zurzolo C: The prion-like spreading of α-synuclein: From in vitro to in vivo models of Parkinson's disease. Ageing Res Rev. 50:89–101. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Wang J, Chen Z, Walston JD, Gao P, Gao M and Leng SX: α-Synuclein activates innate immunity but suppresses interferon-γ expression in murine astrocytes. Eur J Neurosci: 10.1111/ejn.13956, 2018 (Epub ahead of print). | |
|
Hua J, Yin N, Xu S, Chen Q, Tao T, Zhang J, Ding J, Fan Y and Hu G: Enhancing the astrocytic clearance of extracellular α-synuclein aggregates by ginkgolides attenuates neural cell injury. Cell Mol Neurobiol. 39:1017–1028. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Chavarría C, Rodríguez-Bottero S, Quijano C, Cassina P and Souza JM: Impact of monomeric, oligomeric and fibrillar alpha-synuclein on astrocyte reactivity and toxicity to neurons. Biochem J. 475:3153–3169. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Liscovitch N and French L: Differential co-expression between α-synuclein and IFN-γ signaling genes across development and in Parkinson's disease. PLoS One. 9(e115029)2014.PubMed/NCBI View Article : Google Scholar | |
|
Wang J, Chen Z, Walston JD, Gao P, Gao M and Leng SX: Interferon-γ potentiates α-synuclein-induced neurotoxicity linked to toll-like receptors 2 and 3 and tumor necrosis factor-α in murine astrocytes. Mol Neurobiol. 56:7664–7679. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Liu CY, Wang X, Liu C and Zhang HL: Pharmacological targeting of microglial activation: New therapeutic approach. Front Cell Neurosci. 13(514)2019.PubMed/NCBI View Article : Google Scholar | |
|
Li Y, Xia Y, Yin S, Wan F, Hu J, Kou L, Sun Y, Wu J, Zhou Q, Huang J, et al: Targeting microglial α-synuclein/TLRs/NF-kappaB/NLRP3 inflammasome axis in Parkinson's disease. Front Immunol. 12(719807)2021.PubMed/NCBI View Article : Google Scholar | |
|
Zhao Y and Yang G: Potential of extracellular vesicles in the Parkinson's disease-pathological mediators and biomarkers. Neurochem Int. 144(104974)2021.PubMed/NCBI View Article : Google Scholar | |
|
Sarlus H and Heneka MT: Microglia in Alzheimer's disease. J Clin Invest. 127:3240–3249. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Neefjes J, Jongsma ML, Paul P and Bakke O: Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol. 11:823–836. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Chhatbar C and Prinz M: The roles of microglia in viral encephalitis: From sensome to therapeutic targeting. Cell Mol Immunol. 18:250–258. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Kong W, Wang X, Yang X, Huang W, Han S, Yin J, Liu W, He X and Peng B: Activation of TRPV1 contributes to recurrent febrile seizures via inhibiting the microglial M2 phenotype in the immature brain. Front Cell Neurosci. 13(442)2019.PubMed/NCBI View Article : Google Scholar | |
|
Gordon J, Lockard G, Monsour M, Alayli A, Choudhary H and Borlongan CV: Sequestration of inflammation in Parkinson's Disease via stem cell therapy. Int J Mol Sci. 23(10138)2022.PubMed/NCBI View Article : Google Scholar | |
|
Stefanova N, Fellner L, Reindl M, Masliah E, Poewe W and Wenning GK: Toll-like receptor 4 promotes α-synuclein clearance and survival of nigral dopaminergic neurons. Am J Pathol. 179:954–963. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Xia Y, Zhang G, Han C, Ma K, Guo X, Wan F, Kou L, Yin S, Liu L, Huang J, et al: Microglia as modulators of exosomal alpha-synuclein transmission. Cell Death Dis. 10(174)2019.PubMed/NCBI View Article : Google Scholar | |
|
Scheiblich H, Bousset L, Schwartz S, Griep A, Latz E, Melki R and Heneka MT: Microglial NLRP3 inflammasome activation upon TLR2 and TLR5 ligation by distinct α-synuclein assemblies. J Immunol. 207:2143–2154. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Watson MB, Richter F, Lee SK, Gabby L, Wu J, Masliah E, Effros RB and Chesselet MF: Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein. Exp Neurol. 237:318–334. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Wallach T, Raden M, Hinkelmann L, Brehm M, Rabsch D, Weidling H, Krüger C, Kettenmann H, Backofen R and Lehnardt S: Distinct SARS-CoV-2 RNA fragments activate Toll-like receptors 7 and 8 and induce cytokine release from human macrophages and microglia. Front Immunol. 13(1066456)2023.PubMed/NCBI View Article : Google Scholar | |
|
Du XY, Xie XX and Liu RT: The role of α-synuclein oligomers in Parkinson's disease. Int J Mol Sci. 21(8645)2020.PubMed/NCBI View Article : Google Scholar | |
|
Zhang YN, Fan JK, Gu L, Yang HM, Zhan SQ and Zhang H: Metabotropic glutamate receptor 5 inhibits α-synuclein-induced microglia inflammation to protect from neurotoxicity in Parkinson's disease. J Neuroinflammation. 18(23)2021.PubMed/NCBI View Article : Google Scholar | |
|
Kim C, Ho DH, Suk JE, You S, Michael S, Kang J, Joong Lee S, Masliah E, Hwang D, Lee HJ and Lee SJ: Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia. Nat Commun. 4(1562)2013.PubMed/NCBI View Article : Google Scholar | |
|
Heidari A, Yazdanpanah N and Rezaei N: The role of Toll-like receptors and neuroinflammation in Parkinson's disease. J Neuroinflammation. 19(135)2022.PubMed/NCBI View Article : Google Scholar | |
|
Yun SP, Kam TI, Panicker N, Kim S, Oh Y, Park JS, Kwon SH, Park YJ, Karuppagounder SS, Park H, et al: Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson's disease. Nat Med. 24:931–938. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Kermorgant M, Fernagut PO, Meissner WG, Arvanitis DN, N'Guyen D, Senard JM and Pavy-Le Traon A: Age and Gender differences in cardiovascular autonomic failure in the transgenic PLP-syn mouse, a model of multiple system atrophy. Front Neurol. 13(874155)2022.PubMed/NCBI View Article : Google Scholar | |
|
Kaji S, Maki T, Kinoshita H, Uemura N, Ayaki T, Kawamoto Y, Furuta T, Urushitani M, Hasegawa M, Kinoshita Y, et al: Pathological endogenous α-synuclein accumulation in oligodendrocyte precursor cells potentially induces inclusions in multiple system atrophy. Stem Cell Reports. 10:356–365. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Dutta S, Hornung S, Kruayatidee A, Maina KN, Del Rosario I, Paul KC, Wong DY, Duarte Folle A, Markovic D, Palma JA, et al: α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophy. Acta Neuropathol. 142:495–511. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Wakabayashi K, Hayashi S, Yoshimoto M, Kudo H and Takahashi H: NACP/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains. Acta Neuropathol. 99:14–20. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Reyes JF, Rey NL, Bousset L, Melki R, Brundin P and Angot E: Alpha-synuclein transfers from neurons to oligodendrocytes. Glia. 62:387–398. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Kisos H, Pukaß K, Ben-Hur T, Richter-Landsberg C and Sharon R: Increased neuronal α-synuclein pathology associates with its accumulation in oligodendrocytes in mice modeling α-synucleinopathies. PLoS One. 7(e46817)2012.PubMed/NCBI View Article : Google Scholar | |
|
Ihse E, Yamakado H, van Wijk XM, Lawrence R, Esko JD and Masliah E: Cellular internalization of alpha-synuclein aggregates by cell surface heparan sulfate depends on aggregate conformation and cell type. Sci Rep. 7(9008)2017.PubMed/NCBI View Article : Google Scholar | |
|
Stefanova N, Reindl M, Neumann M, Kahle PJ, Poewe W and Wenning GK: Microglial activation mediates neurodegeneration related to oligodendroglial alpha-synucleinopathy: Implications for multiple system atrophy. Mov Disord. 22:2196–2203. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Raffaele S, Boccazzi M and Fumagalli M: Oligodendrocyte dysfunction in amyotrophic lateral sclerosis: Mechanisms and therapeutic perspectives. Cells. 10(565)2021.PubMed/NCBI View Article : Google Scholar | |
|
Ratnam NM, Sonnemann HM, Frederico SC, Chen H, Hutchinson MND, Dowdy T, Reid CM, Jung J, Zhang W, Song H, et al: Reversing epigenetic gene silencing to overcome immune evasion in CNS malignancies. Front Oncol. 11(719091)2021.PubMed/NCBI View Article : Google Scholar | |
|
Tait AS, Butts CL and Sternberg EM: The role of glucocorticoids and progestins in inflammatory, autoimmune, and infectious disease. J Leukoc Biol. 84:924–931. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Enzmann G, Kargaran S and Engelhardt B: Ischemia-reperfusion injury in stroke: Impact of the brain barriers and brain immune privilege on neutrophil function. Ther Adv Neurol Disord. 11(1756286418794184)2018.PubMed/NCBI View Article : Google Scholar | |
|
Chandra G, Roy A, Rangasamy SB and Pahan K: Induction of adaptive immunity leads to nigrostriatal disease progression in MPTP mouse model of Parkinson's disease. J Immunol. 198:4312–4326. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Earls RH, Menees KB, Chung J, Barber J, Gutekunst CA, Hazim MG and Lee JK: Intrastriatal injection of preformed alpha-synuclein fibrils alters central and peripheral immune cell profiles in non-transgenic mice. J Neuroinflammation. 16(250)2019.PubMed/NCBI View Article : Google Scholar | |
|
Sun C, Jia G, Wang X, Wang Y and Liu Y: Immunoproteasome is up-regulated in rotenone-induced Parkinson's disease rat model. Neurosci Lett. 738(135360)2020.PubMed/NCBI View Article : Google Scholar | |
|
Ferreira SA and Romero-Ramos M: Microglia response during Parkinson's Disease: Alpha-synuclein intervention. Front Cell Neurosci. 12(247)2018.PubMed/NCBI View Article : Google Scholar | |
|
Kannarkat GT, Cook DA, Lee JK, Chang J, Chung J, Sandy E, Paul KC, Ritz B, Bronstein J, Factor SA, et al: Common genetic variant association with altered HLA expression, synergy with pyrethroid exposure, and risk for Parkinson's disease: An observational and case-control study. NPJ Parkinsons Dis. 1(15002)2015.PubMed/NCBI View Article : Google Scholar | |
|
Galiano-Landeira J, Torra A, Vila M and Bové J: CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease. Brain. 143:3717–3733. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Rostami J, Fotaki G, Sirois J, Mzezewa R, Bergström J, Essand M, Healy L and Erlandsson A: Astrocytes have the capacity to act as antigen-presenting cells in the Parkinson's disease brain. J Neuroinflammation. 17(119)2020.PubMed/NCBI View Article : Google Scholar | |
|
Sulzer D, Alcalay RN, Garretti F, Cote L, Kanter E, Agin-Liebes J, Liong C, McMurtrey C, Hildebrand WH, Mao X, et al: T cells from patients with Parkinson's disease recognize α-synuclein peptides. Nature. 546:656–661. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Lindestam Arlehamn CS, Dhanwani R, Pham J, Kuan R, Frazier A, Rezende Dutra J, Phillips E, Mallal S, Roederer M, Marder KS, et al: α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson's disease. Nat Commun. 11(1875)2020.PubMed/NCBI View Article : Google Scholar | |
|
Kwon JH, Kim M, Um S, Lee HJ, Bae YK, Choi SJ, Hwang HH, Oh W and Jin HJ: Senescence-associated secretory phenotype suppression mediated by small-sized mesenchymal stem cells delays cellular senescence through TLR2 and TLR5 signaling. Cells. 10(63)2021.PubMed/NCBI View Article : Google Scholar | |
|
Xu Z, Qu A, Zhang H, Wang W, Hao C, Lu M, Shi B, Xu L, Sun M, Xu C and Kuang H: Photoinduced elimination of senescent microglia cells in vivo by chiral gold nanoparticles. Chem Sci. 13:6642–6654. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Badanjak K, Fixemer S, Smajić S, Skupin A and Grünewald A: The contribution of microglia to neuroinflammation in Parkinson's disease. Int J Mol Sci. 22(4676)2021.PubMed/NCBI View Article : Google Scholar | |
|
Chaib S, Tchkonia T and Kirkland JL: Cellular senescence and senolytics: The path to the clinic. Nat Med. 28:1556–1568. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Choi I, Zhang Y, Seegobin SP, Pruvost M, Wang Q, Purtell K, Zhang B and Yue Z: Microglia clear neuron-released α-synuclein via selective autophagy and prevent neurodegeneration. Nat Commun. 11(1386)2020.PubMed/NCBI View Article : Google Scholar | |
|
Menon R, Behnia F, Polettini J, Saade GR, Campisi J and Velarde M: Placental membrane aging and HMGB1 signaling associated with human parturition. Aging (Albany NY). 8:216–230. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Wang AS, Nakamizo S, Ishida Y, Klassen G, Chong P, Wada A, Lim JSY, Wright GD, Kabashima K and Dreesen O: Identification and quantification of senescent cell types by lamin B1 and HMGB1 in Actinic keratosis lesions. J Dermatol Sci. 105:61–64. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Johmura Y, Yamanaka T, Omori S, Wang TW, Sugiura Y, Matsumoto M, Suzuki N, Kumamoto S, Yamaguchi K, Hatakeyama S, et al: Senolysis by glutaminolysis inhibition ameliorates various age-associated disorders. Science. 371:265–270. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Enokido Y, Yoshitake A, Ito H and Okazawa H: Age-dependent change of HMGB1 and DNA double-strand break accumulation in mouse brain. Biochem Biophys Res Commun. 376:128–133. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Mandke P and Vasquez KM: Interactions of high mobility group box protein 1 (HMGB1) with nucleic acids: Implications in DNA repair and immune responses. DNA Repair (Amst). 83(102701)2019.PubMed/NCBI View Article : Google Scholar | |
|
Gaikwad S, Puangmalai N, Bittar A, Montalbano M, Garcia S, McAllen S, Bhatt N, Sonawane M, Sengupta U and Kayed R: Tau oligomer induced HMGB1 release contributes to cellular senescence and neuropathology linked to Alzheimer's disease and frontotemporal dementia. Cell Rep. 36(109419)2021.PubMed/NCBI View Article : Google Scholar | |
|
Yang JH, Petty CA, Dixon-McDougall T, Lopez MV, Tyshkovskiy A, Maybury-Lewis S, Tian X, Ibrahim N, Chen Z, Griffin PT, et al: Chemically induced reprogramming to reverse cellular aging. Aging (Albany NY). 15:5966–5989. 2023.PubMed/NCBI View Article : Google Scholar | |
|
Sarkar TJ, Quarta M, Mukherjee S, Colville A, Paine P, Doan L, Tran CM, Chu CR, Horvath S, Qi LS, et al: Transient non-integrative expression of nuclear reprogramming factors promotes multifaceted amelioration of aging in human cells. Nat Commun. 11(1545)2020.PubMed/NCBI View Article : Google Scholar | |
|
Browder KC, Reddy P, Yamamoto M, Haghani A, Guillen IG, Sahu S, Wang C, Luque Y, Prieto J, Shi L, et al: In vivo partial reprogramming alters age-associated molecular changes during physiological aging in mice. Nat Aging. 2:243–253. 2022.PubMed/NCBI View Article : Google Scholar |
